International Journal of Nanomedicine

We are pleased to announce a new Article Collection in the International Journal of Nanomedicine, dedicated to the game-changing role of lipid nanoparticles (LNP) in the area of mRNA Therapeutics. Since their clinical introduction, mRNA-LNP therapeutics have revolutionized patient care, offering significant benefits in speed of development, therapeutic efficacy, and targeted delivery for eligible patients.

Given the global importance of mRNA-LNP vaccines in COVID-19, and their potential for use in other infectious diseases, cancer, and genetic disorders, the International Journal of Nanomedicine is inviting submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies.

The Collection, edited by Editor-In-Chief Prof. RDK Misra, will be included in Taylor and Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of LNP in mRNA therapeutics, the Editors are particularly interested in manuscripts relating to the following areas:

• Novel lipid nanoparticle formulations and characterization
• Optimization of mRNA delivery systems and targeting strategies
• Scalable manufacturing processes & stability optimization
• mRNA-based vaccines for infectious disease
• mRNA-based therapies for genetic diseases including metabolic disorders, hemophilia, and neurological conditions
• Cancer vaccines and immunotherapies

Please review the journal’s aims and scope and author submission instructions prior to submission. 

Please submit your manuscript through the Dovepress website. During submission, enter the promo code 0BEC2 for a 20% discount on the publishing fee and to indicate that your submission is for consideration in this Article Collection. The manuscript submission deadline is 30 June 2026.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Nanomedicine for Cancer and Autoimmune Immunotherapy", organized by Dr. Yonghyun Lee (Ewha Womans Unniversity, South Korea).

Immune-mediated diseases, including autoimmune disorders and cancer, represent major global health burdens arising from immune system dysfunction. Conventional therapies aim to suppress or activate immune responses, yet their lack of specificity often results in systemic toxicity, off-target effects, and limited therapeutic efficacy. Current immunotherapies often involve a trade-off between therapeutic efficacy and safety. In autoimmune diseases, broad immunosuppression increases infection risk, causes systemic side effects, and provides limited activity at disease sites. In cancer, immunotherapies such as immune checkpoint blockade, cancer vaccines, and tumor microenvironment (TME) modulators aim to activate antitumor responses but often lack specificity, leading to systemic toxicity and limited effectiveness. Therefore, the development of nanotechnology-based therapeutic strategies is urgently needed to enhance target-site efficacy while minimizing systemic side effects in both cancer immunotherapy and autoimmune disease treatment.

Nanomedicine has emerged as a promising approach to address these challenges by enabling precise control over drug release, biodistribution, and immune cell targeting. Using nanocarriers, immunomodulatory agents can be selectively delivered to inflamed tissues or lymphoid organs via various administration routes, including intravenous, subcutaneous, intramuscular, oral, and mucosal. With rational nanocarrier design and route optimization, nanomedicine facilitates context-specific immune modulation—tailoring therapies to induce either anti-inflammatory or immunostimulatory effects with high precision. This strategy offers particular promise for achieving localized immunosuppression in autoimmune diseases and enhancing tumor-specific immunity in cancer therapy.

This Collection aims to spotlight recent advances in nanomedicine that harness diverse delivery strategies to fine-tune immune responses in both autoimmune diseases and cancer immunotherapy. Thus, this Collection invites submissions focused on nanomedicine-based strategies for immune modulation in both autoimmune diseases and cancer immunotherapy. We welcome original research articles and comprehensive reviews. Interdisciplinary contributions that integrate pharmaceutics, nanotechnology, immunology, and translational science are particularly encouraged.

Relevant topics include, but are not limited to: (1) nanomedicine for cancer immunotherapy, including the targeted delivery of antigens, immune enhancers, or modulators to tumors or lymphoid tissues; and (2) nanomedicine for autoimmune diseases, involving site-specific delivery of antigens or immunosuppressive agents to inflamed tissues or immune organs.

This Collection aims to catalyze the development of next-generation immune-modulating therapies that are safer, more effective, and precisely targeted.

Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code 855FE to indicate that your submission is for consideration in this Article Collection. The manuscript submission deadline is 30 April 2026. 

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection. 

Guest advisor

Prof. Yonghyun Lee, Ewha Womans Unniversity

[email protected]

Professor Yonghyun Lee is an Associate Professor at the College of Pharmacy, Ewha Womans University. He is focusing on the development of innovative strategies, aimed at targeted-modulating gut microbiome, apoptosis, and/or immune systems for the effective management of inflammation-related diseases, especially inflammatory bowel diseases, and cancer. He has published extensively in high-impact journals such as Nature Materials, Nature Communications, Angewandte Chemie, and ACS Nano. Also, he has been recognized with multiple research excellence awards including the KAST Promising Young Scientist Award and Ewha’s Award for Research Excellence.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Smart Colloidal Systems for Biomedical Applications", organized by Prof. Xin Li, Prof. Zhiyuan Shi, and Prof. Andrij Pich.

Smart colloidal systems are an innovative class of materials capable of undergoing significant and reversible changes in response to external stimuli such as temperature, pH, light, electric and magnetic fields, or biological signals. Due to their tunable properties, biocompatibility, and degradability, these materials have garnered significant attention in the field of biomedical applications. They are widely utilized in areas such as controlled drug delivery, tissue engineering, biosensors, medical device coatings, and wound healing. The advantages of smart colloidal systems include high sensitivity, specificity, and customizability for different biomedical needs. However, challenges remain in their synthesis, scalability, long-term biocompatibility, and cost-effectiveness. Despite these hurdles, smart colloidal systems hold tremendous potential to revolutionize healthcare by offering advanced and responsive solutions tailored to the dynamic requirements of biological systems.

The study of smart colloidal systems for biomedical applications is of paramount importance due to their potential to address critical challenges in modern healthcare. These advanced materials offer unique capabilities, such as responsiveness to external stimuli (e.g., temperature, pH, light, and biological signals), which enable precise control over their behavior in complex biological environments. This responsiveness allows for the development of innovative solutions, such as targeted drug delivery systems that improve therapeutic efficacy while minimizing side effects, and stimuli-sensitive colloids that promote tissue regeneration in a controlled manner.

Furthermore, smart colloidal systems can mimic or interact with biological systems, making them highly suitable for applications like biosensors, implant coatings, and wound healing materials. Their biocompatibility and degradability ensure that they can be safely integrated into the body or used in temporary applications without long-term adverse effects. Moreover, as the prevalence of chronic diseases, drug resistance, and aging-related conditions continues to rise, smart colloidal systems provide a versatile platform for developing more effective and personalized medical treatments.

Research in this area also drives innovation in materials science, enabling the creation of more efficient, cost-effective, and sustainable colloidal systems. Ultimately, understanding and advancing smart colloidal systems is crucial for improving healthcare outcomes, reducing treatment burdens, and addressing the growing global demand for advanced medical technologies.

Smart colloidal systems represent a transformative research area at the intersection of materials science and biomedicine, offering innovative solutions to address pressing healthcare challenges. This Collection focuses on advances in the design, synthesis, and biomedical applications of smart colloids, emphasizing their stimuli-responsive properties and their ability to interact with complex biological systems. Subtopics of interest include, but are not limited to, smart colloids for drug delivery systems, tissue engineering scaffolds, biosensors, medical device coatings, and wound healing materials. Studies exploring polymer biocompatibility, biodegradability, and scalability for clinical applications are also highly encouraged.

The Collection welcomes original research articles, reviews, and perspectives that provide critical insights or highlight emerging trends in this rapidly evolving field. Contributions focusing on translational research, including preclinical or clinical evaluations of smart colloidal systems, are particularly valued, as they align with the journal’s aim to bridge fundamental science and biomedical innovation.

Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code 4FCD0 to indicate that your submission is for consideration in this Article Collection. The manuscript submission deadline is 31 July 2026.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisors

Prof. Xin Li, City University of Hong Kong, China

[email protected]

Xin Li is a Research Assistant Professor at Department of Biomedical Engineering, City University of Hong Kong. He received his doctoral degree from RWTH Aachen University (Germany). Subsequently, he conducted research at DWI-Leibniz-Institute for Interactive Materials (Germany), The Hong Kong University of Science and Technology, and The Chinese University of Hong Kong. His current research focus on smart microgels for biomedical applications, and he has published 80+ research articles/book chapters, 100+ patents, and 20+ international/national awards.

Prof. Zhiyuan Shi, Tianjin University, China

[email protected]

Zhiyuan Shi is a Professor and Principal Investigator (PI) at the School of Pharmaceutical Science and Technology, Tianjin University. She completed her undergraduate studies in Biology at the University of Göttingen, Germany, and subsequently obtained a Master's degree in Biomedical Engineering and a Ph.D. in Chemistry from the RWTH Aachen University, Germany. From 2020 to the end of 2022, she worked on bispecific antibody development at the University of Cologne, Germany. In 2023, she joined Tianjin University full-time to conduct independent scientific research. Dr. Shi has been dedicated to research in the fields of sonopharmacology and sonogenetics. She pioneered the introduction of mechanical switch structures into drug systems, using ultrasound and other mechanical forces to regulate the chemical properties of drugs, thereby achieving precise control over their pharmacodynamics and pharmacokinetics. She has developed various mechanochemical prodrug activation systems, providing a novel theoretical and technical framework for drug development.

Prof. Andrij Pich, RWTH Aachen University, Germany

[email protected]

In 2009 Andrij Pich was appointed to Lichtenberg Professor for Functional and Interactive Polymers at RWTH Aachen University. Since 2019 he is also a Professor for Biobased Polymers at Maastricht University (part time professorship). After studying chemical technology in Lviv/Ukraine he received his PhD from the Technical University Dresden in 2001. In 2006/2007 he was a postdoctoral fellow at the University of Toronto/Canada. In 2007 he received the Georg Manecke Award of the GDCh (German Chemical Society) and completed his habilitation in 2008 at Technical University Dresden. His research focusses on the synthesis of functional polymers and polymer colloids with variable chemical structures and morphologies and their use for the design of functional and interactive materials.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Advanced Nanomedicine Strategies for Targeted Drug Delivery and Precision Therapeutics", organized by Prof. Jonghoon Choi (Chung-Ang University, South Korea).

The field of nanomedicine has revolutionized the landscape of modern therapeutics by offering unprecedented control over the delivery of pharmaceutical agents. By utilizing engineered nanomaterials, researchers can now navigate complex biological environments to deliver drugs specifically to diseased tissues while minimizing systemic side effects. This Article Collection focuses on the latest breakthroughs in nanocarrier design, including the development of bio-responsive materials, lipid-based nanoparticles, and metallic nanostructures. We aim to explore how these platforms are being refined to improve solubility, stability, and the pharmacokinetic profiles of both small molecules and biologics.

Despite significant laboratory success, the clinical translation of nanomedicine remains a critical challenge. Understanding the interaction between nanomaterials and the biological milieu—such as the protein corona and immune system evasion—is essential for developing effective therapies. This Collection is vital because it bridges the gap between fundamental materials science and clinical application. By highlighting strategies that overcome physiological barriers, such as the blood-brain barrier or the dense stroma of solid tumors, this collection provides a roadmap for the next generation of precision medicine that can adapt to individual patient needs.

We invite submissions that cover a broad spectrum of nanomedicine applications, including but not limited to:

• Mitochondrial targeting and organelle-specific delivery.
• Stimuli-responsive drug release mechanisms (pH, temperature, or enzyme-activated).
• Nano-bio interactions and toxicity assessments.
• Scale-up and manufacturing challenges for clinical trials. We welcome Original Research articles, and Comprehensive Reviews. All manuscripts must align with the journal's scope of advancing drug delivery technology.

Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code 54176 to indicate that your submission is for consideration in this Article Collection. The manuscript submission deadline is 31 January 2027.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisor

Prof. Jonghoon Choi, Chung-Ang University

[email protected]

Professor Choi is a full professor at the Chung-Ang University specializing in nanomedicine and biotechnology. His research focuses on the development of advanced drug delivery systems and functional nanomaterials for therapeutic applications. He has published extensively in high-impact journals regarding the medical applications of biodegradable materials and targeted delivery platforms. He is committed to advancing the field of bioengineering through both research and academic leadership.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Artificial Intelligence Enabled Nanotechnology for Precision Theranostics", organized by Prof. Mohamed Kchaou (University of Bisha, Saudi Arabia) and Prof. Md Faiyazuddin (ARAM Institute, India).

Artificial Intelligence (AI)-enabled nanotechnology is rapidly reshaping the design and application of advanced nanomaterials for biomedical diagnostics and drug delivery systems. The convergence of AI techniques—such as machine learning, deep learning, and predictive modeling—with functional nanomaterials (e.g., nanoparticles, nanocomposites, and stimuli-responsive systems) enables the rational design of highly efficient and adaptive healthcare solutions. This coupling between computational intelligence and material engineering facilitates precise control over physicochemical properties, targeted delivery, and real-time biological interactions. In diagnostics, AI-driven nanoplatforms enhance sensitivity and specificity through intelligent signal processing and biomarker recognition, enabling early and accurate disease detection. In parallel, AI-assisted optimization of drug loading, release kinetics, and targeting mechanisms significantly improves therapeutic outcomes while minimizing side effects. This Article Collection aims to explore recent advances at this interdisciplinary interface, highlighting how AI–nanomaterial integration is driving the development of next-generation, data-driven, and patient-centered diagnostic and therapeutic systems.

This convergence is critical as healthcare systems face increasing demands for early diagnosis, personalized treatment, and improved therapeutic efficiency. Conventional diagnostic and drug delivery approaches often suffer from limited sensitivity, poor targeting, and high variability in patient response. AI-enabled nanomaterials address these challenges by enabling data-driven design, predictive performance, and adaptive functionality at the nanoscale. This leads to faster, more accurate diagnostics and safer, more effective therapies. Ultimately, such integrated technologies have the potential to reduce healthcare costs, accelerate clinical translation, and support the transition toward precision and personalized medicine.

This Article Collection covers the development and application of AI-enabled nanotechnology, particularly nanomaterials, within the scope of nanomedicine, focusing on their roles in advanced diagnostics and targeted drug delivery. Topics of interest include:

• Design of functional nanoparticles (e.g., lipid-based, polymeric, metallic, and hybrid nanostructures),
• AI-assisted nanotechnology optimization, and intelligent nanosystems for disease detection and therapy,
• Biosensing platforms, imaging-enhanced nanodiagnostics, stimuli-responsive drug delivery, and nano–bio interactions,
• Computational modeling, data-driven design, and translational nanomedicine.

Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code 9A8F2 to indicate that your submission is for consideration in this Article Collection. The manuscript submission deadline is 31 January 2027.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisors

Prof. Mohamed Kchaou, University of Bisha

[email protected]

Prof. Mohamed Kchaou is a Full Professor at the University of Bisha, Saudi Arabia, and a Senior Researcher in sustainability and advanced materials. He is ranked among the Stanford–Elsevier World’s Top 2% Scientists (2025) and has received multiple awards for excellence in research, innovation, and academic leadership. He has authored more than 200 scientific contributions, including over 130 peer-reviewed journal articles, and has established a strong international collaboration network with leading universities and research centers worldwide. His research focuses on the integration of artificial intelligence with advanced nanomaterials for healthcare, energy, and circular economy applications, with a particular emphasis on AI-enabled nanomedicine and emerging technologies for societal impact.

Prof. Md Faiyazuddin, ARAM Institute

[email protected]

Prof. Md Faiyazuddin is Professor & Principal at ARAM Institute, India, and Former Dean (R&D) and Professor of Pharmaceutics at Al-Karim University. He also serves as Adjunct Professor at SIMATS and UniKL Global Research Fellow (GloRe). With over 19 years of experience across academia and industry in India and Saudi Arabia, he has held senior leadership roles, including Business Director at Nano Drug Delivery® USA. His research focuses on AI-enabled nanomedicine and advanced drug delivery systems, integrating artificial intelligence with engineered nanomaterials to develop targeted therapeutic platforms. He has authored more than 200 scientific contributions, including over 130 peer-reviewed journal articles, with over 2400 citations (h-index 25). A recipient of the DST Young Scientist and Dr. P.D. Sethi Awards, his work emphasizes translational innovation in pharmaceutical sciences.

View all papers in this article collection